ATS 2018 International Conference - Mobile

Kenneth B. Newman

MD

Verona Pharma

Session(s)

Low Oral Bioavailability of RPL554, a First-in-Class Dual PDE3/4 Inhibitor, Demonstrates t...
Monday, May 21 11:15 AM - 1:00 PM
RPL554, A First-In-Class Dual PDE3/4 Inhibitor, Causes Rapid Additional Bronchodilation Wh...
Monday, May 21 2:15 PM - 4:15 PM